Paediatric Research Institute
Pediatric Research Institute (PFI) is a joint university and hospital institute, and is a research unit at the Division of Pediatric and Adolescent Medicine. Children’s Clinical Research Unit (KFPB) is part of the PFI.
Pediatric Research Institute was established as a joint university and hospital institute at the Rikshospitalet in 1959, and is today a research unit at the Division of Pediatric and Adolescent Medicine.
During the first years, the research at the institute focused on hematology. However, soon after a whole range of topics were established, including metabolic diseases, pediatric cancer, and adverse effects of bilirubin.
Important studies concerning the effect of peptides on diseases have been conducted at the institute. For the past 20 years, the research focus has been on the effect of hypoxia-reoxygenation injury, especially during the neonatal period.
Today the research encompasses a whole range of pediatric diseases, including newborn medicine, pediatric heart disease, kidney disease, pediatric cancer, liver disease and gastroenterology. In addition, our biobank coordinator assists all the research groups at the Division of Pediatric and Adolescent Medicine in designing and developing different biobanks.
Children’s Clinical Research Unit (KFPB) is part of the Pediatric Research Institute. The unit’s study nurses and researchers/doctors play an important role in industry- as well as research-based clinical studies of children and youth, both within and outside of the Division of Pediatric and Adolescent Medicine.
We have established a number of animal models and cell culture models at the Institute, including stem cell research. PFI collaborates extensively with many research groups in Norway and abroad.
Runar Almaas is head of PFI.